| Name: | Rubén Zapata-Pérez |
| Nationality: | Spanish |
| MSc education: | Biology – Molecular Biology, University of Murcia, Spain |
| PhD education: | Molecular Biology and Biotechnology, University of Murcia, Spain |
| Postdoc education: | Cell biology – Metabolism, Amsterdam UMC, the Netherlands |
| Current position: | Assistant Professor |
| Social media handles: | X (@RZapataPerez), LinkedIn |
| Description of my lab’s work: | Our research group is focused on the application of novel therapies based on classical and novel NAD+ enhancers in combination with other bioactive compounds to in vitro and in vivo models of inherited or acquired mitochondrial diseases. |
| Top 3 publications: | Biotechnological production of reduced and oxidized NAD+ precursors – PubMed (nih.gov) Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome – PMC (nih.gov) Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice – Zapata‐Pérez – 2021 – The FASEB Journal – Wiley Online Library |
| Favorite way to keep NAD levels high: | Supplementation with reduced NAD+ precursors (specially NMNH) |